High depression prevalence in patients from a reference outpatient in fibromyalgia
DOI:
https://doi.org/10.25118/2763-9037.2022.v12.222Keywords:
depression, fibromyalgia, disabilityAbstract
Introduction: Fibromyalgia (FM) is a chronic painful syndrome, which frequently co-occurs with depression, but the indexes of this co-occurrence are inconsistent among studies, showing large variability. Objective: Investigating and comparing the depression prevalence in patients coming from FM service of “Conjunto Hospitalar de Sorocaba“ with patients without FM from primary care. As well as, to evaluate age, socioeconomic status, employment, and being user of mental health service among these populations. Method: It was a cross-section study where were evaluated 35 women with FM and 27 women from primary care. Depression was assessed by the Beck Depression Inventory, for the others variables we used a sociodemographic questionnaire. The FM sample was mostly female, so we chose to exclude the men from the analysis. We compared the samples results according to sample provenience, and lately we evaluated only the FM sample, when we performed an exploratory correlations analysis, then the FM sample was separated in with depression and without depression to explore potentials differences among variables. Results: The depression prevalence observed was 65,7% in the FM sample and 29,6% in the without FM sample. Besides, the FM women were older (53,6 years older and 40 years older respectively), with more retirement/home stay rates, lower socio-economic indexes, and making previous use of mental health service, compared to the no FM. Conclusion: Given the high prevalence of depression and in our results, we could suggest that all patients diagnosed with fibromyalgia should be systematically screened to depression, aiming early diagnoses and interventions.
Downloads
Metrics
References
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg, DL, Häuser W, Katz RS, Mease P, Russell AS, Jon Russell I, Winfield JB. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol. 2011; 38(6):1113-22. https://doi.org/10.3899/jrheum.100594 - PMid:21285161 DOI: https://doi.org/10.3899/jrheum.100594
Kleykamp BA, Ferguson MC, McNicol E, Bixho I, Arnold LM, Edwards RR, Fillingim R, Grol-Prokopczyk H, Turk DC, Dworkin RH. The Prevalence of Psychiatric and Chronic Pain Comorbidities in Fibromyalgia: an ACTTION systematic review. Semin Arthritis Rheum. 2021;51(1):166-174. https://doi.org/10.1016/j.semarthrit.2020.10.006 - PMid:33383293 DOI: https://doi.org/10.1016/j.semarthrit.2020.10.006
Gomes-Oliveira MH, Gorenstein C, Lotufo Neto F, Andrade LH, Wang YP. Validation of the Brazilian Portuguese version of the Beck Depression Inventory-II in a community sample. Braz J Psychiatry. 2012 Dec;34(4):389-94. https://doi.org/10.1016/j.rbp.2012.03.005 - PMid:23429809 DOI: https://doi.org/10.1016/j.rbp.2012.03.005
Associação Brasileira de Empresas de Pesquisa. Critério de Classificação Econômica Brasil. 2019. http://www.abep.org/download Accessed 28 Feb 2021.
Kendall, PC, Hollon, SD, Beck, AT, Hammen CL, Ingram RE. Issues and recommendations regarding use of the Beck Depression Inventory. Cogn Ther Res. 1987;11:289-299. https://doi.org/10.1007/BF01186280 DOI: https://doi.org/10.1007/BF01186280
Vitaliano CG, Martins JP, Moreira PAO, Vieira EEC. Relações entre sintomas depressivos, dor e impacto da fibromialgia na qualidade de vida em mulheres. REFACS. 2020;8(2):267-273. https://doi.org/10.18554/refacs.v8i2.4332 DOI: https://doi.org/10.18554/refacs.v8i2.4332
Gonçalves AMC, Teixeira MTB, Gama JRA, Lopes CS, Silva GA, Gamarra CJ, Duque KCD. Prevalência de depressão e fatores associados em mulheres atendidas pela Estratégia de Saúde da Família. J Bras Psiquiatr. 2018;67(2):101-9. https://doi.org/10.1590/0047-2085000000192 DOI: https://doi.org/10.1590/0047-2085000000192
Ferrari AJ, Charlson FJ, Norman RE, Flaxman AD, Patten SB, Vos T, Whiteford HA. The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010. PLoS One. 2013;8(7):e69637. https://doi.org/10.1371/journal.pone.0069637 PMid:23922765 - PMCid:PMC3726670 DOI: https://doi.org/10.1371/journal.pone.0069637
Løge-Hagen JS, Sæle A, Juhl C, Bech P, Stenager E, Mellentin AI. Prevalence of depressive disorder among patients with fibromyalgia: Systematic review and meta-analysis. J Affect Disord. 2019; 245:1098-1105. https://doi.org/10.1016/j.jad.2018.12.001 - PMid:30699852 DOI: https://doi.org/10.1016/j.jad.2018.12.001
Duque L, Fricchione G. Fibromyalgia and its New Lessons for Neuropsychiatry. Med Sci Monit Basic Res. 2019;25:169-178. https://doi.org/10.12659/MSMBR.915962 - PMid:31273184 PMCid:PMC6636402 DOI: https://doi.org/10.12659/MSMBR.915962
Chang MH, Hsu JW, Huang KL, Su TP, Bai YM, Cheng-Ta L, Yang AC, Chang WH, Chen TJ, Tsai SJ, Chen MH. Bidirectional Association Between Depression and Fibromyalgia Syndrome: A Nationwide Longitudinal Study. J Pain. 2015;16(9):895-902. https://doi.org/10.1016/j.jpain.2015.06.004 - PMid:26117813 DOI: https://doi.org/10.1016/j.jpain.2015.06.004
Bonadiman CSC, Malta DC, Azeredo-Passos VM, Naghavi M, Melo APS. Depressive disorders in Brazil: results from the Global Burden of Disease Study 2017. Popul Health Metrics. 2020;18,6. https://doi.org/10.1186/s12963-020-00204-5 - PMid:32993670 PMCid:PMC7526360 DOI: https://doi.org/10.1186/s12963-020-00204-5
Downloads
Published
How to Cite
Conference Proceedings Volume
Section
License
Copyright (c) 2022 Sofia Gonçalves Tonoli , Ana Júlia Campi Nunes de Oliveira, Andre Joko Henna, José Eduardo Martinez, Elaine Aparecida Dacol Henna (Autor)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
